Physician profile
Alejandro Franco
NPI 1871692715
$1,273.69
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $102 · 2022: $284 · 2023: $265 · 2024: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $217.71 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $179.86 | 2019-2022 | |
| Stryker Corporation | $173.39 | 2019-2022 | |
| Abbvie INC. | $124.85 | 2024 | |
| Terumo Medical Corporation | $103.58 | 2019 | |
| Amarin Pharma, INC. | $101.56 | 2020 | |
| Medtronic, INC. | $99.54 | 2023 | Accuvac, Endurant Iis |
| Becton, Dickinson and Company | $94.94 | 2023 | Arista Ah Flexitip |
| Teleflex LLC | $87.54 | 2024 | Titan Sgs |
| Coopersurgical, INC. | $70.96 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Novartis Pharmaceuticals Corporation | $19.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Franco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.